Day One Biopharmaceuticals, Inc. (DAWN)
Delisted
24 Apr 2026
NASDAQ (NGS) NASDAQ (NGS) Primary $
21. 53
0
0%
After Hours
$
+0.97 +4.5053% 22. 50
2.22B Market Cap
- P/E Ratio
- Div Yield
2.67M Volume
- Eps
$ 21.53
Previous Close Investors:
Day Range
21.53 21.53
Year Range
5.63 21.53
Want to track DAWN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Day One Biopharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 282 | $3,150.95 | $6,046 | $2,895.05 | 91.88% |
 Bobby Adusumilli SJS Investment Consulting Inc. | 39 | $0.6 | $0.37 | -$0.23 | -38.33% |
 Kevin Kroskey True Wealth Design LLC | 128 | $2,430.42 | $1,196.31 | -$1,234.11 | -50.78% |
 Mathieu Cornu Pictet Asset Management Holding SA | 13,034 | $121,476.88 | $121,476.88 | - | - |
| MC Megan Claucherty Kodai Capital Management LP | 34,685 | $275,052 | $275,052 | - | - |
